# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 10, "Adv Ther .", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasJournal> \"Adv Ther .\"."
1, PublicationYear, 11, 15, "2014", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasPublicationYear> \"2014\"."
2, Randomized, 109, 119, "Randomized", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
54, Title, 109, 243, "Randomized trial of brinzolamide / brimonidine versus brinzolamide plus brimonidine for open - angle glaucoma or ocular hypertension .", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasTitle> \"Randomized trial of brinzolamide / brimonidine versus brinzolamide plus brimonidine for open - angle glaucoma or ocular hypertension .\"."
38466, Brinz/BrimoFC, 129, 155, "brinzolamide / brimonidine", "", 
3, Brinzolamide, 129, 141, "brinzolamide", "", 
4, Brimonidine, 144, 155, "brimonidine", "", 
5, Brinzolamide, 163, 175, "brinzolamide", "", 
6, Brimonidine, 181, 192, "brimonidine", "", 
7, OpenAngleGlaucoma, 197, 218, "open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma>."
8, OcularHypertension, 222, 241, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
9, Author, 244, 255, "Gandolfi SA", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasAuthor> \"Gandolfi SA\"."
10, Author, 264, 269, "Lim J", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasAuthor> \"Lim J\"."
11, Author, 272, 282, "Sanseau AC", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasAuthor> \"Sanseau AC\"."
12, Author, 285, 302, "Parra Restrepo JC", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasAuthor> \"Parra Restrepo JC\"."
13, Author, 305, 315, "Hamacher T", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasAuthor> \"Hamacher T\"."
14, Italy, 471, 476, "Italy", "", "<http://ctro/data#Population_94507> <http://ctro/data#hasCountry> <http://ctro/data#Italy>."
18, ObjectiveDescription, 528, 713, "Fixed - combination intraocular pressure ( IOP ) - lowering medications simplify treatment regimens for patients requiring 2 ocular hypotensive agents to maintain sufficiently low IOP .", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasObjectiveDescription> \"Fixed - combination intraocular pressure ( IOP ) - lowering medications simplify treatment regimens for patients requiring 2 ocular hypotensive agents to maintain sufficiently low IOP .\"."
15, IOP, 548, 568, "intraocular pressure", "", 
16, IOP, 571, 574, "IOP", "", 
17, IOP, 708, 711, "IOP", "", 
92, ObjectiveDescription, 714, 900, "The aim of this study was to evaluate the safety and efficacy of fixed - combination brinzolamide 1 % / brimonidine 0 . 2 % ( BBFC ) versus concomitant administration of brinzolamide 1 %", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasObjectiveDescription> \"The aim of this study was to evaluate the safety and efficacy of fixed - combination brinzolamide 1 % / brimonidine 0 . 2 % ( BBFC ) versus concomitant administration of brinzolamide 1 %\"."
94, Brinzolamide, 799, 811, "brinzolamide", "", "<http://ctro/data#Medication_94515> <http://ctro/data#hasDrug> <http://ctro/data#Brinzolamide>."
38467, Brinz/BrimoFC, 799, 837, "brinzolamide 1 % / brimonidine 0 . 2 %", "", 
96, DoseValue, 812, 813, "1", "", "<http://ctro/data#Medication_94515> <http://ctro/data#hasDoseValue> \"1\"."
33381, Percentage, 814, 815, "%", "", "<http://ctro/data#Medication_94515> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
95, Brimonidine, 818, 829, "brimonidine", "", "<http://ctro/data#Medication_94522> <http://ctro/data#hasDrug> <http://ctro/data#Brimonidine>."
97, DoseValue, 830, 835, "0 . 2", "", "<http://ctro/data#Medication_94522> <http://ctro/data#hasDoseValue> \"0 . 2\"."
33382, Percentage, 836, 837, "%", "", "<http://ctro/data#Medication_94522> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
38468, Brinz/BrimoFC, 840, 844, "BBFC", "", 
101, Brinzolamide, 884, 896, "brinzolamide", "", "<http://ctro/data#Medication_94545> <http://ctro/data#hasDrug> <http://ctro/data#Brinzolamide>."
99, DoseValue, 897, 898, "1", "", "<http://ctro/data#Medication_94545> <http://ctro/data#hasDoseValue> \"1\"."
33383, Percentage, 899, 900, "%", "", "<http://ctro/data#Medication_94545> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
93, ObjectiveDescription, 901, 1008, "plus brimonidine 0 . 2 % ( BRINZ  +  BRIM ) in patients with open - angle glaucoma or ocular hypertension .", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasObjectiveDescription> \"plus brimonidine 0 . 2 % ( BRINZ  +  BRIM ) in patients with open - angle glaucoma or ocular hypertension .\"."
102, Brimonidine, 906, 917, "brimonidine", "", "<http://ctro/data#Medication_94552> <http://ctro/data#hasDrug> <http://ctro/data#Brimonidine>."
98, DoseValue, 918, 923, "0 . 2", "", "<http://ctro/data#Medication_94552> <http://ctro/data#hasDoseValue> \"0 . 2\"."
33384, Percentage, 924, 925, "%", "", "<http://ctro/data#Medication_94552> <http://ctro/data#hasDoseUnit> <http://ctro/data#Percentage>."
103, OpenAngleGlaucoma, 962, 983, "open - angle glaucoma", "", 
104, OcularHypertension, 987, 1006, "ocular hypertension", "", 
60185, Prospective, 1030, 1041, "prospective", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasCTDesign> <http://ctro/data#Prospective>."
21, Multicenter, 1054, 1065, "multicenter", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
22, DoubleBlind, 1068, 1083, "double - masked", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
23, Duration, 1086, 1095, "6 - month", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasCTduration> \"6 - month\"."
33387, Precondition, 1104, 1215, "Patients who had insufficient IOP control with monotherapy or who were receiving   2 IOP - lowering medications", "", "<http://ctro/data#Population_94507> <http://ctro/data#hasPrecondition> \"Patients who had insufficient IOP control with monotherapy or who were receiving   2 IOP - lowering medications\"."
24, IOP, 1134, 1137, "IOP", "", 
25, IOP, 1189, 1192, "IOP", "", 
26, Randomized, 1221, 1231, "randomized", "", 
115, AllocationRatio, 1232, 1237, "1 : 1", "", "<http://ctro/data#AllocationRatio_94488> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#AllocationRatio>. <http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasAllocationRatio> <http://ctro/data#AllocationRatio_94488>."
116, Frequency, 1249, 1262, "twice - daily", "", "<http://ctro/data#Intervention_94529> <http://ctro/data#hasFrequency> \"twice - daily\". <http://ctro/data#Intervention_94559> <http://ctro/data#hasFrequency> \"twice - daily\"."
38469, Brinz/BrimoFC, 1263, 1267, "BBFC", "", 
38475, Brinzolamide, 1271, 1276, "BRINZ", "", 
38476, Brimonidine, 1281, 1285, "BRIM", "", 
29, IOP, 1288, 1291, "IOP", "", 
119, TimePoint, 1340, 1346, "week 2", "", 
120, TimePoint, 1349, 1355, "week 6", "", 
121, TimePoint, 1358, 1365, "month 3", "", 
122, TimePoint, 1372, 1379, "month 6", "", 
31, Mean, 1423, 1427, "mean", "", 
30, Diurnal_IOP, 1428, 1439, "diurnal IOP", "", 
121, TimePoint, 1464, 1471, "month 3", "", 
33, Mean, 1623, 1627, "mean", "", 
34, IOP, 1628, 1631, "IOP", "", 
35, IOP, 1634, 1637, "IOP", "", 
33394, EndPointDescription, 1665, 1709, "percentage of patients with IOP  < 18   mmHg", "", 
129, IOP, 1693, 1696, "IOP", "", 
130, mmHg, 1705, 1709, "mmHg", "", 
37, Mean, 1757, 1761, "mean", "", "<http://ctro/data#Mean_94577> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_94575> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_94577>."
38, Diurnal_IOP, 1762, 1773, "diurnal IOP", "", "<http://ctro/data#Endpoint_94575> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP>."
38474, Brinz/BrimoFC, 1800, 1804, "BBFC", "", 
133, LeastSquaresMean, 1807, 1825, "least squares mean", "", 
42, Reduction, 1847, 1852, "8 . 5", "", "<http://ctro/data#Outcome_94615> <http://ctro/data#hasChangeValue> \"8 . 5\"."
135, SdErrorChangeValue, 1857, 1863, "0 . 16", "", "<http://ctro/data#Outcome_94615> <http://ctro/data#hasSdErrorChangeValue> \"0 . 16\"."
46, mmHg, 1866, 1870, "mmHg", "", "<http://ctro/data#Endpoint_94575> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
38472, Brinzolamide, 1902, 1907, "BRINZ", "", 
38473, Brimonidine, 1912, 1916, "BRIM", "", 
44, Reduction, 1921, 1926, "8 . 3", "", "<http://ctro/data#Outcome_94642> <http://ctro/data#hasChangeValue> \"8 . 3\"."
138, SdErrorChangeValue, 1931, 1937, "0 . 16", "", "<http://ctro/data#Outcome_94642> <http://ctro/data#hasSdErrorChangeValue> \"0 . 16\"."
47, mmHg, 1940, 1944, "mmHg", "", 
48, Mean, 1947, 1951, "mean", "", 
33398, DiffGroupAbsValue, 1963, 1970, "- 0 . 1", "", "<http://ctro/data#DiffBetweenGroups_94669> <http://ctro/data#hasDiffGroupAbsValue> \"- 0 . 1\"."
50, mmHg, 1973, 1977, "mmHg", "", 
143, ConfIntervalDiff, 1980, 2004, "95 % CI - 0 . 5 to 0 . 2", "", "<http://ctro/data#DiffBetweenGroups_94669> <http://ctro/data#hasConfIntervalDiff> \"95 % CI - 0 . 5 to 0 . 2\"."
52, mmHg, 2007, 2011, "mmHg", "", 
39, ObservedResult, 2016, 2088, "The upper limits of the 95 % CIs were  < 1 . 5   mmHg at all time points", "", "<http://ctro/data#Outcome_94615> <http://ctro/data#hasObservedResult> \"The upper limits of the 95 % CIs were  < 1 . 5   mmHg at all time points\". <http://ctro/data#Outcome_94642> <http://ctro/data#hasObservedResult> \"The upper limits of the 95 % CIs were  < 1 . 5   mmHg at all time points\"."
145, mmHg, 2065, 2069, "mmHg", "", 
38477, TimePoint, 2106, 2114, "baseline", "", 
58, mmHg, 2122, 2126, "mmHg", "", 
33399, LeastSquaresMean, 2145, 2163, "least squares mean", "", 
56, Diurnal_IOP, 2164, 2175, "diurnal IOP", "", 
57, TimePoint, 2203, 2209, "week 2", "", 
167, TimePoint, 2227, 2247, "the end of the study", "", 
61, ObservedResult, 2344, 2540, "The most common ocular adverse drug reactions were hyperemia of the eye ( reported as ocular or conjunctival hyperemia ) , visual disturbances , ocular allergic reactions , and ocular discomfort .", "", "<http://ctro/data#Outcome_94678> <http://ctro/data#hasObservedResult> \"The most common ocular adverse drug reactions were hyperemia of the eye ( reported as ocular or conjunctival hyperemia ) , visual disturbances , ocular allergic reactions , and ocular discomfort .\". <http://ctro/data#Outcome_94705> <http://ctro/data#hasObservedResult> \"The most common ocular adverse drug reactions were hyperemia of the eye ( reported as ocular or conjunctival hyperemia ) , visual disturbances , ocular allergic reactions , and ocular discomfort .\". <http://ctro/data#Outcome_94732> <http://ctro/data#hasObservedResult> \"The most common ocular adverse drug reactions were hyperemia of the eye ( reported as ocular or conjunctival hyperemia ) , visual disturbances , ocular allergic reactions , and ocular discomfort .\". <http://ctro/data#Outcome_94759> <http://ctro/data#hasObservedResult> \"The most common ocular adverse drug reactions were hyperemia of the eye ( reported as ocular or conjunctival hyperemia ) , visual disturbances , ocular allergic reactions , and ocular discomfort .\"."
59, ConjunctivalHyperemia, 2395, 2404, "hyperemia", "", "<http://ctro/data#Endpoint_94580> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#ConjunctivalHyperemia>."
60, ConjunctivalHyperemia, 2440, 2462, "conjunctival hyperemia", "", 
33403, EndPointDescription, 2467, 2486, "visual disturbances", "AdverseEffect", "<http://ctro/data#EndPointDescription_94586> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_94585> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_94586>."
33401, EndPointDescription, 2489, 2514, "ocular allergic reactions", "AdverseEffect", "<http://ctro/data#EndPointDescription_94591> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_94590> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_94591>."
33402, EndPointDescription, 2521, 2538, "ocular discomfort", "AdverseEffect", "<http://ctro/data#EndPointDescription_94596> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_94595> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_94596>."
62, ObservedResult, 2541, 2642, "Common systemic adverse drug reactions included dysgeusia , oral dryness , and fatigue / drowsiness .", "", "<http://ctro/data#Outcome_94786> <http://ctro/data#hasObservedResult> \"Common systemic adverse drug reactions included dysgeusia , oral dryness , and fatigue / drowsiness .\". <http://ctro/data#Outcome_94813> <http://ctro/data#hasObservedResult> \"Common systemic adverse drug reactions included dysgeusia , oral dryness , and fatigue / drowsiness .\". <http://ctro/data#Outcome_94840> <http://ctro/data#hasObservedResult> \"Common systemic adverse drug reactions included dysgeusia , oral dryness , and fatigue / drowsiness .\"."
33404, EndPointDescription, 2589, 2598, "dysgeusia", "AdverseEffect", "<http://ctro/data#EndPointDescription_94601> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_94600> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_94601>."
92879, OralDryness, 2601, 2613, "oral dryness", "", "<http://ctro/data#Endpoint_94605> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#OralDryness>."
33406, EndPointDescription, 2620, 2640, "fatigue / drowsiness", "AdverseEffect", "<http://ctro/data#EndPointDescription_94611> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_94610> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_94611>."
69, ConclusionComment, 2656, 2793, "Brinzolamide 1 % / brimonidine 0 . 2 % fixed combination was as well tolerated and effective as concomitant therapy with its components .", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasConclusionComment> \"Brinzolamide 1 % / brimonidine 0 . 2 % fixed combination was as well tolerated and effective as concomitant therapy with its components .\"."
38470, Brinz/BrimoFC, 2656, 2694, "Brinzolamide 1 % / brimonidine 0 . 2 %", "", 
63, Brinzolamide, 2656, 2668, "Brinzolamide", "", 
65, DoseValue, 2669, 2670, "1", "", 
67, Percentage, 2671, 2672, "%", "", 
64, Brimonidine, 2675, 2686, "brimonidine", "", 
66, DoseValue, 2687, 2692, "0 . 2", "", 
68, Percentage, 2693, 2694, "%", "", 
160, ConclusionComment, 2794, 2885, "BBFC reduces treatment burden in patients who require multiple IOP - lowering medications .", "", "<http://ctro/data#ClinicalTrial_94484> <http://ctro/data#hasConclusionComment> \"BBFC reduces treatment burden in patients who require multiple IOP - lowering medications .\"."
38471, Brinz/BrimoFC, 2794, 2798, "BBFC", "", 
70, IOP, 2857, 2860, "IOP", "", 
72, PMID, 2954, 2962, "25430900", "", "<http://ctro/data#Publication_94473> <http://ctro/data#hasPMID> \"25430900\"."
